Cargando…
Update on Novel Therapeutics for Primary CNS Lymphoma
SIMPLE SUMMARY: Primary central nervous system lymphoma is a rare and aggressive form of non-Hodgkin lymphoma. While it is highly responsive to first-line chemo and radiation treatments, rates of relapse are high, demonstrating the need for improved therapeutic strategies. Recent advancements in the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582401/ https://www.ncbi.nlm.nih.gov/pubmed/34771535 http://dx.doi.org/10.3390/cancers13215372 |